 Breast Neoplasms
"Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the human BREAST.
| Descriptor ID |
D001943
|
| MeSH Number(s) |
C04.588.180 C17.800.090.500
|
| Concept/Terms |
Breast Neoplasms- Breast Neoplasms
- Breast Neoplasm
- Neoplasm, Breast
- Breast Tumors
- Breast Tumor
- Tumor, Breast
- Tumors, Breast
- Neoplasms, Breast
Breast Carcinoma- Breast Carcinoma
- Breast Carcinomas
- Carcinoma, Breast
- Carcinomas, Breast
Mammary Neoplasms, Human- Mammary Neoplasms, Human
- Human Mammary Neoplasm
- Human Mammary Neoplasms
- Neoplasm, Human Mammary
- Neoplasms, Human Mammary
- Mammary Neoplasm, Human
Breast Cancer- Breast Cancer
- Cancer, Breast
- Mammary Cancer
- Cancer, Mammary
- Cancers, Mammary
- Mammary Cancers
- Malignant Neoplasm of Breast
- Breast Malignant Neoplasm
- Breast Malignant Neoplasms
- Malignant Tumor of Breast
- Breast Malignant Tumor
- Breast Malignant Tumors
- Cancer of Breast
- Cancer of the Breast
|
Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms".
This graph shows the total number of publications written about "Breast Neoplasms" by people in this website by year, and whether "Breast Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 10 | 5 | 15 | | 1997 | 5 | 3 | 8 | | 1998 | 16 | 2 | 18 | | 1999 | 20 | 2 | 22 | | 2000 | 35 | 5 | 40 | | 2001 | 24 | 2 | 26 | | 2002 | 33 | 7 | 40 | | 2003 | 21 | 6 | 27 | | 2004 | 30 | 4 | 34 | | 2005 | 43 | 6 | 49 | | 2006 | 31 | 8 | 39 | | 2007 | 40 | 7 | 47 | | 2008 | 40 | 6 | 46 | | 2009 | 49 | 5 | 54 | | 2010 | 44 | 7 | 51 | | 2011 | 47 | 11 | 58 | | 2012 | 52 | 8 | 60 | | 2013 | 68 | 11 | 79 | | 2014 | 70 | 12 | 82 | | 2015 | 72 | 12 | 84 | | 2016 | 66 | 8 | 74 | | 2017 | 58 | 8 | 66 | | 2018 | 56 | 9 | 65 | | 2019 | 60 | 7 | 67 | | 2020 | 91 | 2 | 93 | | 2021 | 82 | 5 | 87 | | 2022 | 79 | 1 | 80 | | 2023 | 67 | 2 | 69 | | 2024 | 65 | 6 | 71 | | 2025 | 75 | 10 | 85 | | 2026 | 25 | 1 | 26 |
To return to the timeline, click here.
Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.
-
Oselinsky KM, Hill EB, Ostendorf DM, Pan Z, Bing K, Wayland LT, Simpson C, Clark KC, Sandoval A, Thomas EA, Marker RJ, Kabos P, MacLean PS, Catenacci VA. Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial. JMIR Res Protoc. 2026 Jul 23; 15:e86281.
-
Morganti S, Kim SE, Jin Q, Cha J, Zeigler JE, Newman AB, Kirkner GJ, Snow C, Zheng Y, Vincuilla J, Parker T, Buehler RM, Bychkovsky BL, Dibble KE, Sella T, Ruddy KJ, Rosenberg SM, Collins LC, Peppercorn J, Schapira L, Borges VF, Guzman-Arocho YD, Come SE, Warner E, Poorvu PD, Lambertini M, Curigliano G, Hughes ME, Mittendorf EA, King TA, Lin NU, Garber JE, Tayob N, Tolaney SM, Partridge AH, Lynce F. Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort studies. JNCI Cancer Spectr. 2026 Jul 07; 10(4).
-
Cortina CS, Brazauskas R, Flanagan MR, Dill ED, Joseph KP, Trifonov A, Mukhtar RA, Kim EA, Kantor O, Barmettler G, Rezak KM, Rosenberger LH, Jordan SW, Perez MM, Jimenez RB, Smart AC, Kopkash KA, Hughes TM, Walker JC, Lautner MA, Siegel EL, Brabender DE, Al-Hilli Z, Cassidy MR, Weiss A, McCaffrey RL, Lee MC, Kaoutzanis C, Nguyen KN, Son JD, Williams AD, Madrigrano A, McLaughlin SA, Petroll AE, Stolley M. Characteristics of Gender-Diverse Patients With Breast Cancer. JAMA Netw Open. 2026 Jul 01; 9(7):e2624824.
-
Mazhindu T, Nyangwara VA, Borok MZ, Masimirembwa C, Flaig T, Campbell TB, Ndlovu N. Doxorubicin-induced early-onset chronic progressive cardiotoxicity, pharmacogenetics and survival among breast cancer patients in Zimbabwe. S Afr Med J. 2026 Jun 02; 116(5):e3655.
-
Tesch ME, Zheng Y, Guzman-Arocho YD, Collins LC, Heng YJ, Tayob N, Rosenberg SM, Ruddy KJ, Tamimi RM, Schapira L, Peppercorn J, Borges V, Come SE, Snow C, Winer EP, Mittendorf EA, Partridge AH. Association of Tumor-Infiltrating Lymphocyte Subtypes with Clinical Characteristics and Prognosis in Young Women with Hormone Receptor-Positive Breast Cancer. Clin Cancer Res. 2026 Jun 01; 32(11):2268-2278.
-
Fox MS, Jaramillo-Gómez JA, Marquez-Ortiz RA, Alvarez-Eraso KLF, Contreras-Zárate MJ, Pham TC, Barela EN, Koliavas SN, Kabos P, Serkova NJ, Sartorius CA, Wellberg EA, Cittelly DM. Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastases. Nat Commun. 2026 May 28; 17(1).
-
Williams MM, Christenson JL, Spoelstra NS, Hafeez SA, Kuo LW, Crump LS, O'Neill KI, Hill AA, Phan A, McCue LM, Hintelmann TM, Ruiz J, Sax HE, Williams J, Boorgula MP, Goodspeed A, Slansky JE, Richer JK. Aggressive breast cancers secrete heme metabolites to alter macrophage immune suppression and function. Commun Biol. 2026 May 09; 9(1).
-
Izaias JE, Ono BE, Sales AO, Rodrigues TS, Silva GMPS, Lima RF, Nunes CS, Bittencourt MA, Pentagna PS, Salemi VMC, Consolim-Colombo FM, Irigoyen MCC, Rodrigues AG, Negrão CE, Testa L, De Angelis K, Porcari AM, Rocha HNM, Teixeira GF, Rocha NG, da Nóbrega ACL, Craighead DH, Clayton ZS, Moll-Bernardes RJ, Sales ARK. Attenuated pressor and sympathetic neural responses to exercise in long-term breast cancer survivors: role of the muscle metaboreflex. Am J Physiol Heart Circ Physiol. 2026 Jun 01; 330(6):H1951-H1959.
-
Sherman ME, Etievant L, Vierkant RA, Winham SJ, Ruddy KJ, Pacheco-Spann L, Wickland DP, Cruz-Reyes N, Stallings-Mann M, Radisky D, Thompson EA, Kachergus JM, Shi J, Rosenberg SM, Snow C, Kirkner GJ, Schapira L, Peppercorn JM, Come S, Borges VF, Warner E, Collins LC, Partridge AH, Pfeiffer RM. Postpartum breast cancer: evidence for a distinct phenotype. J Natl Cancer Inst. 2026 May 01; 118(5):926-936.
-
Knudsen ES, Witkiewicz AK, Kabraji S. The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond. Nat Rev Drug Discov. 2026 Jul; 25(7):516-533.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|